These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22761054)

  • 1. Dendrimers--revolutionary drugs for infectious diseases.
    Lazniewska J; Milowska K; Gabryelak T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):469-91. PubMed ID: 22761054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Dendrimers for the Treatment of Infectious Diseases.
    Mhlwatika Z; Aderibigbe BA
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials.
    García-Gallego S; Franci G; Falanga A; Gómez R; Folliero V; Galdiero S; de la Mata FJ; Galdiero M
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28934169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of the concept of infectious disease and guidelines for its prevention and therapy in the light of the acquisitions of the past 25 years].
    Tolentino P
    Recenti Prog Med; 1976 Oct; 61(4):476-98. PubMed ID: 799822
    [No Abstract]   [Full Text] [Related]  

  • 5. Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.
    Filipczak N; Yalamarty SSK; Li X; Parveen F; Torchilin V
    Molecules; 2021 May; 26(11):. PubMed ID: 34072765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.
    Ter Meulen J
    Infect Dis Clin North Am; 2011 Dec; 25(4):789-802. PubMed ID: 22054756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key pathogens and emerging therapies in infectious diseases.
    Miller PF; Mueller JP
    Curr Opin Pharmacol; 2009 Oct; 9(5):535-6. PubMed ID: 19766536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimers as versatile platform in drug delivery applications.
    Svenson S
    Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimer toxicity: Let's meet the challenge.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.
    Yellepeddi VK; Kumar A; Palakurthi S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):835-50. PubMed ID: 19637972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
    Soliman GM; Sharma A; Maysinger D; Kakkar A
    Chem Commun (Camb); 2011 Sep; 47(34):9572-87. PubMed ID: 21655634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the investigation of biological effect and surface modification of dendrimers as drug (gene) delivery systems].
    He ZH; Kong H; Xu HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):590-5. PubMed ID: 16995320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties--an overview.
    Reichling J; Schnitzler P; Suschke U; Saller R
    Forsch Komplementmed; 2009 Apr; 16(2):79-90. PubMed ID: 19420953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimers against fungi - A state of the art review.
    Mlynarczyk DT; Dlugaszewska J; Kaluzna-Mlynarczyk A; Goslinski T
    J Control Release; 2021 Feb; 330():599-617. PubMed ID: 33347941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases.
    Niederhafner P; Reinis M; Sebestík J; Jezek J
    J Pept Sci; 2008 May; 14(5):556-87. PubMed ID: 18275089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectiology and tropical medicine 2007].
    Löbermann M; Reisinger EC
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1399-403. PubMed ID: 17570089
    [No Abstract]   [Full Text] [Related]  

  • 18. Host-guest chemistry of dendrimer-drug complexes. 2. Effects of molecular properties of guests and surface functionalities of dendrimers.
    Hu J; Cheng Y; Wu Q; Zhao L; Xu T
    J Phys Chem B; 2009 Aug; 113(31):10650-9. PubMed ID: 19603764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers in drug research.
    Boas U; Heegaard PM
    Chem Soc Rev; 2004 Jan; 33(1):43-63. PubMed ID: 14737508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of antiadhesins--a new prospective trend in preventing and treating infectious diseases (a foundation for the technologies for creating drugs in the 21st century)].
    Skrypal' IH
    Mikrobiol Z; 1997; 59(6):63-74. PubMed ID: 9511377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.